New Discoveries and Honors in Cancer Research

Read the latest cancer research and recognition from the members of the Damon Runyon scientific circle.
April 21, 2013
Identification of novel targets to block cancer cell metabolism

Matthew G. Vander Heiden, MD, PhD (Damon Runyon-Rachleff Innovator ‘11-‘13, Damon Runyon Fellow ‘06-‘08) of MIT, Cambridge, and colleagues, reported the results of a large study analyzing gene expression data from 22 tumor types. They identified multiple changes in genes that regulate metabolism in cancer cells. The analysis also identified hundreds of potential drug targets that could block tumor growth. The study was published in the journal Nature Biotechnology.